Part 2: Factor in Pharmacy's Role in Hemophilia Management
Date & Time:
Thursday, March 15, 2018
6:00pm - 6:30pm Registration and Dinner
6:30pm - 7:15pm Part 1 Presentation (no CPE)
7:30pm - 8:30pm Part 2 Presentation (CPE)
Location:
Ditka's Oakbrook Terrace
2 Mid America Plaza - Suite 100
Oakbrook Terrace, IL 60181
(630) 572-2200
Presented By:
Part 1: The Rising Tide of Gram-Negative ResistanceMichael Angarone, DO
Transplant Infectious Disease; Associate Professor
Northwestern Memorial Hospital, Chicago, IL
Part 1 is not available for CPE credit. Provided by Allergan.
In accordance with the PhRMA Code on interactions with Healthcare Professionals, attendance at this educational program is limited to healthcare professionals. As such, attendance by guests or spouses is not permitted.
By accepting any food and/or refreshments at this program, you represent that neither your employer nor the particular state(s) in which you are licensed impose restrictions that preclude you from accepting these items. This invitation is non-transferrable.
Part 2: Factor in Pharmacy's Role in Hemophilia Management
Giles W. Slocum, PharmD
Emergency Medicine Clinical Pharmacist
Rush University Medical Center, Chicago, IL
Part 2 is accredited for pharmacists and pharmacy technicians | 1.0 contact hour (0.1 CEU)
This is an independent program provided by ICHP.
Registration:
Register online below. Registration deadline is Friday, March 9, at 9:00 am.
This program is free to ICHP members. However, those who do not attend and do not cancel at least 48 hours prior to the program will be charged $50 to cover expenses. Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
Seating is limited to the first 45 people. Student seating will limited to the first 10 students. Registration is closed for students.
Learning Objectives for Pharmacists:
1. Identify the different severities of hemophilia and the potential complications that may occur.
2. Describe how to appropriately dose clotting factor 8, clotting factor 9, and inhibitor bypassing agents in the setting of an acute bleed.
3. Explain ways a pharmacist can help provide more efficient and effective clotting factor use.
Learning Objectives for Technicians:
1. Select the correct clotting factor deficiency for each of the hemophilia types.
2. Identify the different severities of hemophilia and the potential complications that may occur.
3. Recognize the importance of timely and correct administration of clotting factor concentrates for hemophiliacs with acute bleeding.
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE Universal Activity Numbers (UANs): 0121-0000-18-019-L01-P & 0121-0000-18-019-L01-T
1.0 Contact Hour (0.1 CEU) Type of Activity: Knowledge-based
Target Audience: Health-System Pharmacists and Pharmacy Technicians
CPE Monitor: When registering for this program, you will be asked to provide your NABP eProfile ID# and Birthday (MMDD) when registering for this meeting. This information is required by any participants seeking CPE credit.
Visit www.ichpnet.org/cpemonitor/ for information about CPE Monitor and how to obtain your NABP ID.
PTCB requires CPhTs to submit 20 hours of pharmacy technician-specific (T-specific ) continuing pharmacy education (CPE) to qualify for recertification. Pharmacy technicians will no long be able to use Pharmacist only or P-specific CPE. In addition, PTCB will reduce the number of allowable CPE hours earned through in-service training from 10 to 5. Please advise all pharmacy technicians at your site of this pending change. As an ACPE accredited provider, ICHP will continue to include Technician specific programming in most if not all of our CPE programming.
